Showing results (371-380 of 458) with videos related to

Sort By:
Pageof 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2022
Epigenetic state determines inflammatory sensing in neuroblastomaAdam J Wolpaw, Liron D Grossmann, Jessica L Dessau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2015
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II studyGregory A Yanik, Judith G Villablanca, John M Maris, et al.
Cell Reports. Medicine|August 2, 2021
A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitopeSwetha Raman, Samantha N Buongervino, Maria V Lane, et al.
The Journal of Experimental Medicine|July 14, 2025
Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastomaMarie Ménard, Hiroyuki Yoda, Nicole Nasholm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2025
D3-GPC2-Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung CancerAnna Maria Giudice, Stephanie Matlaga, Sydney L Roth, et al.
Communications Biology|November 18, 2022
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastomaMehran Makvandi, Minu Samanta, Paul Martorano, et al.
Cancer Research|August 16, 2023
Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid TumorsApexa Modi, Gonzalo Lopez, Karina L Conkrite, et al.
Frontiers in Immunology|June 30, 2017
HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer ImmunotherapyAmy K Erbe, Wei Wang, Patrick K Reville, et al.
Nature|August 30, 2008
Identification of ALK as a major familial neuroblastoma predisposition geneYaël P Mossé, Marci Laudenslager, Luca Longo, et al.
Pageof 46